Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zucchetti

Showing results (341-350 of 479) with videos related to

Pageof 48
Sort By:
Neoplasia (New York, N.Y.)|December 19, 2016
In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer ModelsFederica Guffanti, Rosaria Chilà, Ezia Bello, et al.
Cancer Chemotherapy and Pharmacology|September 30, 2021
Venetoclax penetrates in cerebrospinal fluid of an acute myeloid leukemia patient with leptomeningeal involvementAnnalisa Condorelli, Cristina Matteo, Salvatore Leotta, et al.
Scientific Reports|December 22, 2016
Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imagingSilvia Giordano, Massimo Zucchetti, Alessandra Decio, et al.
World Journal of Cardiology|September 29, 2015
Electrical storm: A clinical and electrophysiological overviewSergio Conti, Salvatore Pala, Viviana Biagioli, et al.
Cancer Chemotherapy and Pharmacology|December 16, 2015
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinomaCarmen Belli, Lorenzo Piemonti, Maurizio D'Incalci, et al.
Nanomaterials (Basel, Switzerland)|March 25, 2017
A Nanostructured Matrices Assessment to Study Drug Distribution in Solid Tumor Tissues by Mass Spectrometry ImagingSilvia Giordano, Valentina Pifferi, Lavinia Morosi, et al.
Targeted Oncology|December 28, 2020
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic ProfileDomenica Lorusso, Giuseppa Maltese, Ilaria Sabatucci, et al.
International Journal of Cardiology|June 13, 2025
Assessing palliative care needs in worsening heart failure patients: Insights from OPPORTUNITIES registryEmilia D'Elia, Ottavio Zucchetti, Francesco Pedrazzoli, et al.
Cancers|August 26, 2022
Work Placement and Job Satisfaction in Long-Term Childhood Cancer Survivors: The Impact of Late EffectsMargherita Dionisi-Vici, Alessandro Godono, Anna Castiglione, et al.
International Journal of Cancer|May 13, 2018
Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumabFrancesca Bizzaro, Francesca Falcetta, Elisa D'Agostini, et al.
Pageof 48

Showing results (341-350 of 479) with videos related to

Sort By:
Pageof 48
Neoplasia (New York, N.Y.)|December 19, 2016
In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer ModelsFederica Guffanti, Rosaria Chilà, Ezia Bello, et al.
Cancer Chemotherapy and Pharmacology|September 30, 2021
Venetoclax penetrates in cerebrospinal fluid of an acute myeloid leukemia patient with leptomeningeal involvementAnnalisa Condorelli, Cristina Matteo, Salvatore Leotta, et al.
Scientific Reports|December 22, 2016
Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imagingSilvia Giordano, Massimo Zucchetti, Alessandra Decio, et al.
World Journal of Cardiology|September 29, 2015
Electrical storm: A clinical and electrophysiological overviewSergio Conti, Salvatore Pala, Viviana Biagioli, et al.
Cancer Chemotherapy and Pharmacology|December 16, 2015
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinomaCarmen Belli, Lorenzo Piemonti, Maurizio D'Incalci, et al.
Nanomaterials (Basel, Switzerland)|March 25, 2017
A Nanostructured Matrices Assessment to Study Drug Distribution in Solid Tumor Tissues by Mass Spectrometry ImagingSilvia Giordano, Valentina Pifferi, Lavinia Morosi, et al.
Targeted Oncology|December 28, 2020
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic ProfileDomenica Lorusso, Giuseppa Maltese, Ilaria Sabatucci, et al.
International Journal of Cardiology|June 13, 2025
Assessing palliative care needs in worsening heart failure patients: Insights from OPPORTUNITIES registryEmilia D'Elia, Ottavio Zucchetti, Francesco Pedrazzoli, et al.
Cancers|August 26, 2022
Work Placement and Job Satisfaction in Long-Term Childhood Cancer Survivors: The Impact of Late EffectsMargherita Dionisi-Vici, Alessandro Godono, Anna Castiglione, et al.
International Journal of Cancer|May 13, 2018
Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumabFrancesca Bizzaro, Francesca Falcetta, Elisa D'Agostini, et al.
Pageof 48